GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

Public Health, Biostatistics, Mathematics +10

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

Medicine, Oncology, Treatment Planning +14

Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy

Cosimo Durante, Nadia Haddy, E. Baudin et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 1.7K citations

Medicine, Oncology, Surgery +17

Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial

Christophe Louvet, Roberto Labianca, Pascal Hammel et al. · Journal of Clinical Oncology · 2005 · 954 citations · Full text

Medicine, Oncology, Pharmacology +12

International patterns and trends in thyroid cancer incidence, 1973–2002

Briseis A. Kilfoy, Tongzhang Zheng, Theodore R. Holford et al. · Cancer Causes & Control · 2008 · 718 citations · Full text

Medicine, Endocrinology, Oncology +13